• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Stability of thioester intermediates in ubiquitin-like modifications.泛素样修饰物中硫酯中间物的稳定性。
Protein Sci. 2009 Dec;18(12):2492-9. doi: 10.1002/pro.254.
2
A stable chemical SUMO1-Ubc9 conjugate specifically binds as a thioester mimic to the RanBP2-E3 ligase complex.一种稳定的化学SUMO1-Ubc9共轭物作为硫酯模拟物特异性结合到RanBP2-E3连接酶复合物上。
Chembiochem. 2015 May 26;16(8):1183-9. doi: 10.1002/cbic.201500011. Epub 2015 Apr 27.
3
Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.由SUMO-RanGAP1-Ubc9-Nup358复合物揭示的E3连接酶活性见解。
Nature. 2005 Jun 2;435(7042):687-92. doi: 10.1038/nature03588.
4
Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.泛素样小分子修饰物SUMO的泛素结合酶Ubc9的纯化及活性测定。
Methods Enzymol. 2005;398:74-87. doi: 10.1016/S0076-6879(05)98008-7.
5
Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.泛素结合酶9(Ubc9)、小泛素样修饰蛋白(SUMO)和Ran结合蛋白2(RanBP2)之间独特的结合相互作用揭示了SUMO旁系同源物选择的机制。
Nat Struct Mol Biol. 2005 Jan;12(1):67-74. doi: 10.1038/nsmb878. Epub 2004 Dec 19.
6
Domain alternation and active site remodeling are conserved structural features of ubiquitin E1.结构域交替和活性位点重塑是泛素E1保守的结构特征。
J Biol Chem. 2017 Jul 21;292(29):12089-12099. doi: 10.1074/jbc.M117.787622. Epub 2017 Jun 1.
7
Specific substrate recognition and thioester intermediate determinations in ubiquitin and SUMO conjugation cascades revealed by a high-sensitive FRET assay.通过高灵敏度荧光共振能量转移分析揭示泛素和类泛素化修饰连接反应级联中的特异性底物识别及硫酯中间体测定
Mol Biosyst. 2014 Apr;10(4):778-86. doi: 10.1039/c3mb70155g. Epub 2014 Jan 23.
8
Mechanism of E1-E2 interaction for the inhibition of Ubl adenylation.UBL 腺苷酸化抑制的 E1-E2 相互作用机制。
J Biol Chem. 2010 Oct 22;285(43):33457-33462. doi: 10.1074/jbc.M110.135582. Epub 2010 Aug 3.
9
Active site remodelling accompanies thioester bond formation in the SUMO E1.活性位点重塑伴随硫酯键在 SUMO E1 中的形成。
Nature. 2010 Feb 18;463(7283):906-12. doi: 10.1038/nature08765.
10
Tag-team SUMO wrestling.接力式小泛素相关修饰物(SUMO)蛋白连接反应
Mol Cell. 2005 Jun 10;18(6):612-4. doi: 10.1016/j.molcel.2005.05.017.

引用本文的文献

1
Production and Purification of SUMO-UBC9 and SUMO-RANGAP1.SUMO-UBC9和SUMO-RANGAP1的制备与纯化。
Methods Mol Biol. 2025;2957:67-82. doi: 10.1007/978-1-0716-4710-3_5.
2
Cysteine -acetylation is a post-translational modification involved in metabolic regulation.半胱氨酸乙酰化是一种参与代谢调节的翻译后修饰。
bioRxiv. 2024 May 21:2024.05.21.595030. doi: 10.1101/2024.05.21.595030.
3
Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic.通过对其稳定类似物的分析,深入了解人类 E2∼SUMO 缀合物的调节结构。
J Biol Chem. 2023 Jul;299(7):104870. doi: 10.1016/j.jbc.2023.104870. Epub 2023 May 27.
4
Thioester and Oxyester Linkages in the Ubiquitin System.泛素系统中的硫酯键和酯键连接。
Methods Mol Biol. 2023;2602:3-18. doi: 10.1007/978-1-0716-2859-1_1.
5
Non-lysine ubiquitylation: Doing things differently.非赖氨酸泛素化:以不同方式行事。
Front Mol Biosci. 2022 Sep 19;9:1008175. doi: 10.3389/fmolb.2022.1008175. eCollection 2022.
6
A new dawn beyond lysine ubiquitination.赖氨酸泛素化之外的新曙光。
Nat Chem Biol. 2022 Aug;18(8):802-811. doi: 10.1038/s41589-022-01088-2. Epub 2022 Jul 27.
7
Hepatitis B Core Protein Is Post-Translationally Modified through K29-Linked Ubiquitination.乙型肝炎核心蛋白通过 K29 连接的泛素化进行翻译后修饰。
Cells. 2020 Nov 26;9(12):2547. doi: 10.3390/cells9122547.
8
Developmental and tissue specific changes of ubiquitin forms in Drosophila melanogaster.果蝇泛素形式的发育和组织特异性变化。
PLoS One. 2018 Dec 13;13(12):e0209080. doi: 10.1371/journal.pone.0209080. eCollection 2018.
9
Evaluating nonpolar surface area and liquid chromatography/mass spectrometry response: an application for site occupancy measurements for enzyme intermediates in polyketide biosynthesis.评估非极性表面积和液相色谱/质谱响应:在聚酮生物合成中用于酶中间体位点占有率测量的应用。
Rapid Commun Mass Spectrom. 2014 Dec 15;28(23):2511-22. doi: 10.1002/rcm.7051.
10
E2 enzyme inhibition by stabilization of a low-affinity interface with ubiquitin.E2 酶通过稳定与泛素的低亲和力界面来抑制。
Nat Chem Biol. 2014 Feb;10(2):156-163. doi: 10.1038/nchembio.1412. Epub 2013 Dec 15.

本文引用的文献

1
Structure of a Shigella effector reveals a new class of ubiquitin ligases.一种志贺氏菌效应蛋白的结构揭示了一类新型泛素连接酶。
Nat Struct Mol Biol. 2008 Dec;15(12):1302-8. doi: 10.1038/nsmb.1517. Epub 2008 Nov 9.
2
Ubc9 sumoylation regulates SUMO target discrimination.泛素结合酶9(Ubc9)的类泛素化修饰调节类泛素化修饰靶点的识别。
Mol Cell. 2008 Aug 8;31(3):371-82. doi: 10.1016/j.molcel.2008.05.022.
3
Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.姐妹着丝粒的分离需要RanBP2介导的拓扑异构酶IIα的SUMO化修饰。
Cell. 2008 Apr 4;133(1):103-15. doi: 10.1016/j.cell.2008.01.045.
4
Chemoenzymatic and template-directed synthesis of bioactive macrocyclic peptides.生物活性大环肽的化学酶法和模板导向合成
Microbiol Mol Biol Rev. 2006 Mar;70(1):121-46. doi: 10.1128/MMBR.70.1.121-146.2006.
5
Measuring protein concentrations by NMR spectroscopy.通过核磁共振光谱法测量蛋白质浓度。
J Am Chem Soc. 2006 Mar 1;128(8):2571-6. doi: 10.1021/ja055336t.
6
Ubiquitin manipulation by an E2 conjugating enzyme using a novel covalent intermediate.E2 缀合酶利用一种新型共价中间体对泛素进行操控。
J Biol Chem. 2005 Sep 9;280(36):31732-8. doi: 10.1074/jbc.M505205200. Epub 2005 Jul 12.
7
Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.由SUMO-RanGAP1-Ubc9-Nup358复合物揭示的E3连接酶活性见解。
Nature. 2005 Jun 2;435(7042):687-92. doi: 10.1038/nature03588.
8
Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.泛素结合酶9(Ubc9)、小泛素样修饰蛋白(SUMO)和Ran结合蛋白2(RanBP2)之间独特的结合相互作用揭示了SUMO旁系同源物选择的机制。
Nat Struct Mol Biol. 2005 Jan;12(1):67-74. doi: 10.1038/nsmb878. Epub 2004 Dec 19.
9
Ubiquitin charging of human class III ubiquitin-conjugating enzymes triggers their nuclear import.人类III类泛素结合酶的泛素化修饰引发其核输入。
J Cell Biol. 2004 Nov 22;167(4):649-59. doi: 10.1083/jcb.200406001. Epub 2004 Nov 15.
10
Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation.干扰素诱导的泛素E2,Ubc8,是一种用于蛋白质ISGylation的缀合酶。
Mol Cell Biol. 2004 Nov;24(21):9592-600. doi: 10.1128/MCB.24.21.9592-9600.2004.

泛素样修饰物中硫酯中间物的稳定性。

Stability of thioester intermediates in ubiquitin-like modifications.

机构信息

Department of Immunology, Beckman Research Institute of the City of Hope, Duarte, California 91010, USA.

出版信息

Protein Sci. 2009 Dec;18(12):2492-9. doi: 10.1002/pro.254.

DOI:10.1002/pro.254
PMID:19785004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2821268/
Abstract

Ubiquitin-like modifications are important mechanisms in cellular regulation, and are carried out through several steps with reaction intermediates being thioester conjugates of ubiquitin-like proteins with E1, E2, and sometimes E3. Despite their importance, a thorough characterization of the intrinsic stability of these thioester intermediates has been lacking. In this study, we investigated the intrinsic stability by using a model compound and the Ubc9 approximately SUMO-1 thioester conjugate. The Ubc9 approximately SUMO-1 thioester intermediate has a half life of approximately 3.6 h (hydrolysis rate k = 5.33 +/- 2.8 x10(-5) s(-1)), and the stability decreased slightly under denaturing conditions (k = 12.5 +/- 1.8 x 10(-5) s(-1)), indicating a moderate effect of the three-dimensional structural context on the stability of these intermediates. Binding to active and inactive E3, (RanBP2) also has only a moderate effect on the hydrolysis rate (13.8 +/- 0.8 x 10(-5) s(-1) for active E3 versus 7.38 +/- 0.7 x 10(-5) s(-1) for inactive E3). The intrinsically high stability of these intermediates suggests that unwanted thioester intermediates may be eliminated enzymatically, such as by thioesterases, to regulate their intracellular abundance and trafficking in the control of ubiquitin-like modifications.

摘要

泛素样修饰是细胞调节中的重要机制,通过几个步骤完成,反应中间体是泛素样蛋白与 E1、E2 以及有时 E3 的硫酯键共轭物。尽管它们很重要,但这些硫酯中间体的固有稳定性的全面表征一直缺乏。在这项研究中,我们使用模型化合物和 Ubc9 与 SUMO-1 的硫酯共轭物来研究固有稳定性。Ubc9 与 SUMO-1 的硫酯中间体的半衰期约为 3.6 小时(水解速率 k = 5.33 +/- 2.8 x10(-5) s(-1)),在变性条件下稳定性略有下降(k = 12.5 +/- 1.8 x 10(-5) s(-1)),这表明三维结构环境对这些中间体的稳定性有适度的影响。与活性和非活性 E3(RanBP2)结合对水解速率的影响也只有适度(活性 E3 的水解速率为 13.8 +/- 0.8 x 10(-5) s(-1),而非活性 E3 的水解速率为 7.38 +/- 0.7 x 10(-5) s(-1))。这些中间体的固有高稳定性表明,不需要的硫酯中间体可能会被酶如硫酯酶消除,以调节它们在细胞内的丰度和运输,从而控制泛素样修饰。